Kristiyana Stoyanova’s Post

The latest collection of articles from the DIA Global Forum is here, and CTTI is honored to have contributed to the special section on Representative Clinical Trials. These articles address the evolving challenges and opportunities in advancing DEI within the clinical research and trials enterprise. Our own Sabrena Mervin-Blake co-authored the series alongside other industry experts. We invite you to read the entire series, reflect on these perspectives, and join us in fostering meaningful progress. Let’s keep the dialogue and momentum going strong! https://lnkd.in/g6kxFc3E 💡 What insights or ideas resonate most with you? Let us know in the comments!

New trade association sets sights on advancing multisite clinical research corporations https://lnkd.in/gpjPVizf As multisite clinical research corporations (MCRCs) proliferate to meet the increased demand for larger clinical trials that span the globe, they’ll have a new trade association to back them up. The Association of Multisite Research [...]

💡 Want to know why Ireland is one of the leading locations for Life Sciences? 👇 Find out more about Ireland's position and offering in the competitive landscape with this concise article.....well worth a quick read!

⏰ The Count-Down is on ⏰ 🔬Ireland's Science Week 2024 will be taking place from the 10th – 17th November. It is a national celebration of science with hundreds of events for people of all ages taking place across Ireland. 🔬 Science Week in 2024 is "harnessing the power of regeneration. The decisions we make today will greatly impact future generations and so it is important to take learnings from the past to inform our decisions for the future. From protecting our natural world, adopting more sustainable approaches to energy supply, embracing technological advancements and investigating new solutions to safeguard our health, it’s time to reimagine the way we engage with the world around us and enhance our collective strengths. This Science Week, there is something for every generation with events happening all over the country". In Ireland right now, it is an exciting time for innovation and exploration, with a spotlight on fields driving technological advancement and healthcare improvements, particularly in the pharmaceutical industry. This week, will , feature workshops, panels, and events where leaders and researchers share cutting-edge insights. This focus is especially relevant for Ireland, home to one of the world’s most robust pharmaceutical sectors, supporting both global companies and a vibrant domestic industry that emphasizes innovation and regulatory excellence. PDA - Parenteral Drug Association's and PDA Ireland's mission is Connecting People, Science and Regulation®. ✅ We encourage all our members and followers to check out the details of events near you this week at the link here: https://lnkd.in/eRwk648 ✅

Annalise Markelin recently attended a BioCrossroads event, where industry leaders, academics, and patient advocates came together to highlight the growing importance of radiopharmaceuticals. The event was a reminder of two truths: meaningful work can create meaningful change, and awareness can transform lives. Check out Annalise's blog post linked in the comments below to read more about her takeaways from the event and how this can impact a mission based recruitment strategy. 👇

💫Meaningful work can create meaningful change and the pursuit of doing good is never done💫 Take a look at my recent blog post that highlights the growth of the radiopharmaceutical industry and what Harba is doing to create a meaningful impact on the industry! https://lnkd.in/d8Tc69bX

Exciting news in the clinical research site network business! Led by Jim Kremidas and 14 site networks, we have launched the Association of Multisite Research Corporations (AMRC). "The trade association’s mission is to promote the unique benefits of multisite clinical research corporations, according to the release. These benefits include scalability, consistency due to centralized operations, data integrity and enhanced support for investigators, the AMRC said."

Inizio Engage XD recently launched their 'Congress Planning Today: Pain Points and Opportunities' report. The free guide helps to identify the challenges faced by congress planners working in pharma and what is hindering the delivery of congress events. Download the research report below to learn more from medical congress organizers as they reveal what is and isn’t working to deliver a successful congress: https://lnkd.in/eFuSk3HY

How can generic medicines better promote equity in low- and middle-income countries? Sharing insights from the Access to Medicine Foundation's research, Claudia Martínez explores the story behind her passion for access to medicine, the industry’s progress in making medicines more widely available and more. Tune in: https://hubs.la/Q02ZSDP20

The BIO International Convention 2024, held in San Diego, has concluded with remarkable success, leaving attendees inspired and optimistic about the future of the biotechnology and life sciences industry. This year’s convention brought together over 20,000 professionals from around the globe, from researchers starting out on their journey’s to industry leading c-suites from around the globe. Follow the link for the key highlights from this year’s event - including several high-profile keynote speakers who provided insightful perspectives on the future of biotechnology. These included: Dr. Jennifer Doudna, Nobel laureate and co-inventor of CRISPR technology, who discussed the latest advancements in gene editing and its potential to revolutionize medicine. Albert Bourla, CEO of Pfizer, who shared the company’s vision for the next decade, emphasizing the role of mRNA technology beyond COVID-19 vaccines. Francis Collins, former director of the National Institutes of Health, who highlighted the importance of global collaboration in addressing pandemics and other health crises. The exhibition hall was a bustling hub of activity, with over 1,800 exhibitors showcasing their latest products and technologies. Attendees also had the opportunity to participate in over 500 sessions, including panel discussions and workshops that covered a wide array of topics. Key sessions focused on: The Future of Digital Health: Exploring how digital tools and AI are transforming healthcare delivery and patient care. Sustainability in Biotechnology: Addressing the environmental impact of biomanufacturing and the steps companies can take to become more sustainable. Diversity and Inclusion in Life Sciences: Strategies to foster a more inclusive workforce and the benefits of diversity in driving innovation. Cpl Life Sciences US played an active role in this year’s convention, showcasing our latest staffing solutions and engaging in meaningful discussions about the future of the life sciences workforce. Highlights from our participation included U.S VP Tom Hancox panel contribution on how to approach your clinical development strategy in the U.S alongside François Ravenelle (CEO of Inversago Pharma), Vanessa Elharrar MD MPH (Global Medical Officer at PPD) & James Ravitz (FDA Lead & Partner at McDermott Will & Emery). The Bio International Convention 2024 has once again proven to be an essential event for anyone involved in the life sciences industry. The innovative ideas, strategic partnerships, and inspiring discussions that emerged from this year’s event will undoubtedly shape the future of biotechnology and healthcare. https://lnkd.in/eKhMvhEh